GlassScriptPhysician profile
Soloman R Singh
NPI 1700981545
$9,370.74
in general payments reported to CMS, 2019-2025
39 companies · $705 in 2025
The $705 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,373 · 2020: $583 · 2021: $413 · 2022: $1,424 · 2023: $2,472 · 2024: $2,400 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,538 · Education: $39.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,538.12 |
| Education | $39.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,091.43 | 2019-2025 | Skyrizi, Mavyret, Linzess |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,580.33 | 2019-2025 | Xifaxan |
| Pfizer INC. | $788.77 | 2019-2025 | |
| Janssen Biotech, INC. | $718.61 | 2019-2025 | Stelara, Simponi, Simponi Aria |
| Ironwood Pharmaceuticals, INC | $374.07 | 2020-2024 | Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $363.02 | 2019-2025 | Entyvio, Gattex |
| Celgene Corporation | $310.44 | 2022-2024 | Zeposia |
| Intercept Pharmaceuticals, INC. | $199.69 | 2019-2025 | Ocaliva |
| Nestle Healthcare Nutrition INC. | $175.94 | 2021-2023 | |
| Ipsen Biopharmaceuticals, INC | $175.33 | 2024-2025 | Iqirvo |
| Lilly USA, LLC | $161.45 | 2024-2025 | Omvoh |
| Aimmune Therapeutics, INC. | $126.85 | 2024 | |
| Phathom Pharmaceuticals, INC. | $110.13 | 2024-2025 | Voquezna |
| Myriad Women'S Health, INC. | $100.21 | 2023 | Myrisk |
| Ferring Pharmaceuticals INC. | $96.56 | 2019-2023 | Rebyota |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $75.00 | 2019-2020 | |
| Boston Scientific Corporation | $73.13 | 2019-2025 | Cre Pro, Resolution 360 Ultra Clip, Watchman Flx |
| Braintree Laboratories, INC. | $72.86 | 2020-2023 | Suflave |
| Ardelyx, INC. | $67.98 | 2024-2025 | Ibsrela |
| Redhill Biopharma INC. | $65.19 | 2022-2024 | Talicia, Aemcolo |
| Romark Laboratories, Lc | $62.22 | 2019-2020 | |
| Madrigal Pharmaceuticals | $61.97 | 2024-2025 | Rezdiffra |
| Genzyme Corporation | $55.81 | 2022-2023 | |
| Amgen INC. | $53.74 | 2023 | Avsola, Amjevita |
| Shionogi INC | $51.04 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $42.64 | 2022 | |
| Pharming Healthcare, INC. | $41.19 | 2020 | |
| Merck Sharp & Dohme LLC | $36.87 | 2019 | |
| Gilead Sciences, INC. | $35.23 | 2019-2021 | |
| Daiichi Sankyo INC. | $33.08 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $31.31 | 2024 | Zeposia |
| Organon LLC | $31.19 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $17.67 | 2022 | |
| Fujifilm Healthcare Americas Corporation | $17.20 | 2023 | Fujifilm |
| Shire North American Group INC | $16.08 | 2019 | |
| Exact Sciences Corporation | $15.84 | 2023 | Cologuard Collection Kit |
| Medtronic, INC. | $14.92 | 2022 | |
| Dova Pharmaceuticals | $13.48 | 2019 | |
| Covidien LP | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soloman Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.